According to the U.S. Food and Drug Administration (FDA), its Compliance Programs exist to provide instructions to FDA personnel for conducting activities to evaluate industry compliance with the Federal Food, Drug, and Cosmetic Act and other laws administered by FDA. On September 30, 2020, FDA released its Compliance Program Guidance Manual (CPGM) titled “Dietary Supplements – Foreign and Domestic Inspections, Sampling, and Imports.” Per FDA, the goal of this CPGM is to ensure companies consistently manufacture dietary supplements of acceptable quality and minimize consumers’ exposure to adulterated and/or misbranded dietary supplements. Attend the webinar on March 18 to hear perspectives on the CPGM from an industry veteran and an FDA investigator. Aaron Secrist will speak from the vantage point of industry, and Justin Boyd will provide insight from FDA’s point of view.

On Tuesday January 19, 2021, USDA issued the Final Rule for the Domestic Hemp Production Program following two rounds of public comments on the Interim Final Rule issued in late 2019. Come listen to a panel of hemp industry experts and regulatory consultants identify what changed, what stayed the same, and what still needs improvement as the industry heads into the 2021 growing season. Panelists will identify and discuss the key changes that impact hemp growers, including the harvest window, sampling protocols, and compliance thresholds.

A national election that many have called the most important in a generation is now behind us. The American Herbal Products Association (AHPA) will host a webinar on November 10, 2020 (2:00-3:30 pm Eastern) to bring together three experts from Van Scoyoc Associates and our AHPA member community for an analysis and discussion of the election, with a particular focus on possible impacts for the herbal products and dietary supplements industries.

Webinar presenters will address different approaches to sustainability self-assessment, discuss various sustainability standards, and how to create realistic science based targets, and present examples that will help companies of all sizes plan and execute meaningful self-assessments.

Webinar presenters explain ways to ensure your marketing claims for herbal immune support products are substantiated, truthful and not misleading. Industry experts review several methods they’ve used to ensure their dietary supplement product claims are well substantiated, including: randomized, controlled clinical trials on a well-known elderberry product; in vitro testing to support the legitimacy of the product; and the relevance of use and training in substantiating the effectiveness of traditional Chinese herbal formulations.

This free webinar provides practical information on how best to resume post-quarantine business operations while protecting your workforce. Learn what personal protective equipment and workspace adaptations should be implemented and how to manage ongoing business risks and liabilities. Additionally, hear from experts about how to be proactive and search for, and then correct, workplace conditions that could increase risk of COVID-19 infections.

This webinar provides guidance and practical tips on how to successfully market your hemp-derived products consistent with the requirements of the FDA and FTC. An FTC representative provides FTC’s perspective, summarizes recent enforcement actions, and discusses the level of substantiation respondents in those actions possessed or did not possess. Industry attorneys address legal standards, today’s ever-evolving regulatory environment, and the lawsuit risks and liabilities marketers of hemp products face.

This webinar provides an overview of dietary supplement current good manufacturing (cGMP) requirements for hemp-CBD products. Legal and industry experts provide strategies and resources to comply and document compliance with  federal manufacturing requirements designed to ensure supplement product quality and safety.